-transparent.png){kind=logo}
International Myeloma Working Group recommendations for global myeloma care. 2014
H Ludwig, and
J S Miguel, and
M A Dimopoulos, and
A Palumbo, and
R Garcia Sanz, and
R Powles, and
S Lentzsch, and
W Ming Chen, and
J Hou, and
A Jurczyszyn, and
K Romeril, and
R Hajek, and
E Terpos, and
K Shimizu, and
D Joshua, and
V Hungria, and
A Rodriguez Morales, and
D Ben-Yehuda, and
P Sondergeld, and
E Zamagni, and
B Durie
Department of Medicine I, Center of Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria.
Recent developments have led to remarkable improvements in the assessment and treatment of patients with multiple myeloma (MM). New technologies have become available to precisely evaluate the biology and extent of the disease, including information about cytogenetics and genetic abnormalities, extramedullary manifestations and minimal residual disease. New, more effective drugs have been introduced into clinical practice, which enable clinicians to significantly improve the outcome of patients but also pose new challenges for the prevention and management of their specific side effects. Given these various new options and challenges, it is important to identify the minimal requirements for diagnosis and treatment of patients, as access to the most sophisticated advances may vary depending on local circumstances. Here, we propose the minimal requirements and possible options for diagnosis, monitoring and treatment of patients with multiple myeloma.
Related Publications
H Ludwig, and
J S Miguel, and
M A Dimopoulos, and
A Palumbo, and
R Garcia Sanz, and
R Powles, and
S Lentzsch, and
W Ming Chen, and
J Hou, and
A Jurczyszyn, and
K Romeril, and
R Hajek, and
E Terpos, and
K Shimizu, and
D Joshua, and
V Hungria, and
A Rodriguez Morales, and
D Ben-Yehuda, and
P Sondergeld, and
E Zamagni, and
B Durie
June 2013,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H Ludwig, and
J S Miguel, and
M A Dimopoulos, and
A Palumbo, and
R Garcia Sanz, and
R Powles, and
S Lentzsch, and
W Ming Chen, and
J Hou, and
A Jurczyszyn, and
K Romeril, and
R Hajek, and
E Terpos, and
K Shimizu, and
D Joshua, and
V Hungria, and
A Rodriguez Morales, and
D Ben-Yehuda, and
P Sondergeld, and
E Zamagni, and
B Durie
August 2025,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H Ludwig, and
J S Miguel, and
M A Dimopoulos, and
A Palumbo, and
R Garcia Sanz, and
R Powles, and
S Lentzsch, and
W Ming Chen, and
J Hou, and
A Jurczyszyn, and
K Romeril, and
R Hajek, and
E Terpos, and
K Shimizu, and
D Joshua, and
V Hungria, and
A Rodriguez Morales, and
D Ben-Yehuda, and
P Sondergeld, and
E Zamagni, and
B Durie
March 2021,
The Lancet. Oncology,
H Ludwig, and
J S Miguel, and
M A Dimopoulos, and
A Palumbo, and
R Garcia Sanz, and
R Powles, and
S Lentzsch, and
W Ming Chen, and
J Hou, and
A Jurczyszyn, and
K Romeril, and
R Hajek, and
E Terpos, and
K Shimizu, and
D Joshua, and
V Hungria, and
A Rodriguez Morales, and
D Ben-Yehuda, and
P Sondergeld, and
E Zamagni, and
B Durie
June 2025,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H Ludwig, and
J S Miguel, and
M A Dimopoulos, and
A Palumbo, and
R Garcia Sanz, and
R Powles, and
S Lentzsch, and
W Ming Chen, and
J Hou, and
A Jurczyszyn, and
K Romeril, and
R Hajek, and
E Terpos, and
K Shimizu, and
D Joshua, and
V Hungria, and
A Rodriguez Morales, and
D Ben-Yehuda, and
P Sondergeld, and
E Zamagni, and
B Durie
September 2015,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H Ludwig, and
J S Miguel, and
M A Dimopoulos, and
A Palumbo, and
R Garcia Sanz, and
R Powles, and
S Lentzsch, and
W Ming Chen, and
J Hou, and
A Jurczyszyn, and
K Romeril, and
R Hajek, and
E Terpos, and
K Shimizu, and
D Joshua, and
V Hungria, and
A Rodriguez Morales, and
D Ben-Yehuda, and
P Sondergeld, and
E Zamagni, and
B Durie
November 2014,
The Lancet. Oncology,
H Ludwig, and
J S Miguel, and
M A Dimopoulos, and
A Palumbo, and
R Garcia Sanz, and
R Powles, and
S Lentzsch, and
W Ming Chen, and
J Hou, and
A Jurczyszyn, and
K Romeril, and
R Hajek, and
E Terpos, and
K Shimizu, and
D Joshua, and
V Hungria, and
A Rodriguez Morales, and
D Ben-Yehuda, and
P Sondergeld, and
E Zamagni, and
B Durie
July 2016,
Nihon rinsho. Japanese journal of clinical medicine,
H Ludwig, and
J S Miguel, and
M A Dimopoulos, and
A Palumbo, and
R Garcia Sanz, and
R Powles, and
S Lentzsch, and
W Ming Chen, and
J Hou, and
A Jurczyszyn, and
K Romeril, and
R Hajek, and
E Terpos, and
K Shimizu, and
D Joshua, and
V Hungria, and
A Rodriguez Morales, and
D Ben-Yehuda, and
P Sondergeld, and
E Zamagni, and
B Durie
December 2009,
Leukemia,
H Ludwig, and
J S Miguel, and
M A Dimopoulos, and
A Palumbo, and
R Garcia Sanz, and
R Powles, and
S Lentzsch, and
W Ming Chen, and
J Hou, and
A Jurczyszyn, and
K Romeril, and
R Hajek, and
E Terpos, and
K Shimizu, and
D Joshua, and
V Hungria, and
A Rodriguez Morales, and
D Ben-Yehuda, and
P Sondergeld, and
E Zamagni, and
B Durie
May 2024,
The Lancet. Oncology,
H Ludwig, and
J S Miguel, and
M A Dimopoulos, and
A Palumbo, and
R Garcia Sanz, and
R Powles, and
S Lentzsch, and
W Ming Chen, and
J Hou, and
A Jurczyszyn, and
K Romeril, and
R Hajek, and
E Terpos, and
K Shimizu, and
D Joshua, and
V Hungria, and
A Rodriguez Morales, and
D Ben-Yehuda, and
P Sondergeld, and
E Zamagni, and
B Durie
June 2025,
The Lancet. Neurology,
